Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cannabidiol Reduces Seizures in Dravet Syndrome

Key clinical point: Adjunctive CBD reduces the rate of convulsive seizures in patients with Dravet syndrome.

Major finding: The 10-mg/kg per day dose reduced the rate of convulsive seizures by 49%.

Study details: A prospective, randomized, placebo-controlled study of 199 children with Dravet syndrome.

Disclosures: GW Research supported the study. Dr. Miller has received compensation and research support from several companies, including GW Pharma.


Miller I et al. AAN 2019, Abstract P3.6-076.